Suppliers / Bills Biotech

Bills Biotech

India Updated 9 July 2026

Bills Biotech is an API manufacturer based in India. It holds one active US drug master file. Its GMP standing is certified by CDSCO (India). Customs aggregates show $682K of exports covering 57 molecules to 13 destinations in 2025.

1
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Vadodara, India 3038882417
vad odara, India Not on file

What they file, and where

Molecule Regulators Docs
Mupirocin US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $141K 4
2025 Not reported $682K 13
2024 Not reported $129K 12
2023 Not reported $384K 4

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Bills Biotech comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts